DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Negative impactResults

Cohance Lifesciences Q2 Results: Net profit plunges 80% on lower revenue, unfavourable product mix

CNBC-TV18 1 hr ago·6 Nov 2026, 1:18 pm

Cohance Life Sciences reported a 79.5% year-on-year decline in Q2 FY27 net profit to ₹15.2 crore, while revenue fell 14.2% to ₹477 crore. The company expects a materially stronger second half, supported by Small Molecule deliveries, reload orders, nucleic-acid growth and improved portfolio performance.

Affected stocks

Bearish1 stock

Cohance Lifesciences

COHANCE Bearish

₹433.55

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Cohance Lifesciences (COHANCE).
Category: Results.
AI reads the tone as negative (potentially bearish) for the stock.
Assessed as a significant, market-relevant update.

Why it matters

A meaningful update for Cohance Lifesciences worth tracking. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at CNBC-TV18.